Get complete Patent Opposition Report for Hexal Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Hexal Pharma

Explore patent oppositions filed by Hexal Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3024461A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial TranslocationEURO CELTIQUEMay 14, 2020
EP2941251Crenolanib For Treating Flt3 Mutated Proliferative DisordersAROG PHARMACEUTICALSDec 7, 2018